BioSpace News Archive

iECURE today announced the appointment of George A. Diaz, M.D. Ph.D., as VP, Therapeutic Area Lead for Urea Cycle Disorders (UCDs).

Cerus Corporation (Nasdaq: CERS) today announced that it has signed a five-year contract with the American Red Cross for the INTERCEPT Blood System for Platelets.

Hologic, Inc. (Nasdaq: HOLX) announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index™ (BCI) within its Clinical Practice Guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.”

Ocular Therapeutix, Inc. announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-4 in Denver, Colorado and May 11-12 virtually.

Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Cardiothoracic and Vascular Anesthesia.

Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi.

Surmodics, Inc. announced today that Gary Ansel, MD, will present First-In-Human (FIH) data on the company’s Pounce™ Thrombectomy System on Tuesday, April 26, at the Charing Cross International Symposium in London.

Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Prashant Kohli, Vice President of Commercial Operations of Acasti Pharma will be presenting at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on Thursday, April 28, 2022 at 4:30 pm ET.

NIDO Surgical announced today the acquisition of its innovative epicardial ablation technology, SEPIA (Solution for Epicardial Ablation), by an undisclosed medical device company involved in the electrophysiology space.

R2 Technologies Inc. (“R2"), the world leader in CryoAesthetic™ medical devices, today announced that they have shipped 100 GLACIAL® devices to customers globally.